The expression profile and clinic significance of the SIX family in non-small cell lung cancer

Emerging roles of Nrf2 signal in non-small cell lung cancer

(2016) Yijun Tian et al.   Journal of Hematology & Oncology

Modification of platinum sensitivity by KEAP1/NRF2 signals in non-small cell lung cancer

(2016) Yijun Tian et al.   Journal of Hematology & Oncology

Expression profile of SIX family members correlates with clinic-pathological features and prognosis of breast cancer

(2016) Han-Xiao Xu et al.   MEDICINE

The retinal determination gene network: from developmental regulator to cancer therapeutic target

(2016) Deguang Kong et al.   Oncotarget

The DACH/EYA/SIX gene network and its role in tumor initiation and progression

(2015) Yu Liu et al.   INTERNATIONAL JOURNAL OF CANCER

NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin

(2015) Dong Suwei et al.   Journal of Hematology & Oncology

Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancer

(2015) Wei Sun et al.   Journal of Hematology & Oncology

The Six1 oncoprotein downregulates p53 via concomitant regulation of RPL26 and microRNA-27a-3p

(2015) Christina G. Towers et al.   Nature Communications

DACH1 inhibits lung adenocarcinoma invasion and tumor growth by repressing CXCL5 signaling

(2015) Na Han et al.   Oncotarget

DACH1 is a novel predictive and prognostic biomarker in hepatocellular carcinoma as a negative regulator of Wnt/β-catenin signaling

(2015) Yu Liu et al.   Oncotarget

Meta-analysis reveals the correlation of Notch signaling with non-small cell lung cancer progression and prognosis

(2015) Xun Yuan et al.   Scientific Reports

Homeoprotein Six2 Promotes Breast Cancer Metastasis via Transcriptional and Epigenetic Control of E-Cadherin Expression

(2014) C.-A. Wang et al.   CANCER RESEARCH

miR-204 functions as a tumor suppressor by regulating SIX1 in NSCLC

(2014) Yang Xia et al.   FEBS LETTERS

DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells

(2014) Qian Chu et al.   Journal of Hematology & Oncology

Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application

(2014) Xun Yuan et al.   Journal of Hematology & Oncology

Dachshund Binds p53 to Block the Growth of Lung Adenocarcinoma Cells

(2013) K. Chen et al.   CANCER RESEARCH

A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non-Small Cell Lung Cancer Patients

(2013) H. Tang et al.   CLINICAL CANCER RESEARCH

Abrogation of Eya1/Six1 disrupts the saccular phase of lung morphogenesis and causes remodeling

(2013) Karol Lu et al.   DEVELOPMENTAL BIOLOGY

Expression of Eya1 and Six1 is decreased in distal airways of rats with experimental pulmonary hypoplasia

(2013) Florian Friedmacher et al.   JOURNAL OF PEDIATRIC SURGERY

Down-Regulation of SIX3 is Associated with Clinical Outcome in Lung Adenocarcinoma

(2013) Min-Li Mo et al.   PLoS One

Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer

(2013) Balázs Győrffy et al.   PLoS One

Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis-Prone Lung Cancers

(2013) S. Rousseaux et al.   Science Translational Medicine

Biomarker Discovery in Non-Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation

(2012) J. Botling et al.   CLINICAL CANCER RESEARCH

Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression

(2012) S. A. Selamat et al.   GENOME RESEARCH

Comprehensive genomic characterization of squamous cell lung cancers

(2012)   NATURE

Identification of Genes Upregulated in ALK-Positive and EGFR/KRAS/ALK-Negative Lung Adenocarcinomas

(2011) H. Okayama et al.   CANCER RESEARCH

Upregulation of Notch2 and Six1 Is Associated with Progression of Early-Stage Lung Adenocarcinoma and a More Aggressive Phenotype at Advanced Stages

(2011) T. Mimae et al.   CLINICAL CANCER RESEARCH

Identification of a Novel Biomarker, SEMA5A, for Non-Small Cell Lung Carcinoma in Nonsmoking Women

(2010) T.-P. Lu et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Eyes absent 1 (Eya1) is a critical coordinator of epithelial, mesenchymal and vascular morphogenesis in the mammalian lung

(2010) Ahmed H.K. El-Hashash et al.   DEVELOPMENTAL BIOLOGY

Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non–Small-Cell Lung Cancer

(2010) Chang-Qi Zhu et al.   JOURNAL OF CLINICAL ONCOLOGY

Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction

(2010) Jun Hou et al.   PLoS One

Relapse-Related Molecular Signature in Lung Adenocarcinomas Identifies Patients With Dismal Prognosis

(2009) Shuta Tomida et al.   JOURNAL OF CLINICAL ONCOLOGY

DNA-Binding and Regulation Mechanisms of the SIX Family of Retinal Determination Proteins†

(2008) Shengyong Hu et al.   BIOCHEMISTRY

Prediction of Recurrence-Free Survival in Postoperative Non-Small Cell Lung Cancer Patients by Using an Integrated Model of Clinical Information and Gene Expression

(2008) E.-S. Lee et al.   CLINICAL CANCER RESEARCH

Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes

(2008) Ruprecht Kuner et al.   LUNG CANCER

Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

(2008) Kerby Shedden et al.   NATURE MEDICINE

Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival

(2008) Maria Teresa Landi et al.   PLoS One